Related Experiment Video
Updated: Sep 20, 2025
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.4K
MDSCs in Chronic Liver Disease: Updates and Future Challenges
Yi Lu1,2, Ting Li2, Liang Song1
1Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
Journal of Gastroenterology and Hepatology
|May 23, 2025
Summary
Myeloid-derived suppressor cells (MDSCs) are key immune cells in chronic liver diseases. Targeting these cells offers potential new treatments for conditions like hepatitis and fatty liver disease.
Area of Science:
- Immunology
- Hepatology
- Cell Biology
Background:
- Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells with potent immunosuppressive functions.
- MDSCs are implicated in various pathologies, including cancer, infections, and inflammatory disorders.
- In chronic liver diseases, MDSCs contribute to pathogenesis and disease progression.
Purpose of the Study:
- To review the biological roles of MDSCs in chronic inflammatory liver diseases.
- To explore the therapeutic potential of targeting MDSCs in liver disease treatment.
Main Methods:
- Literature review of studies on MDSCs in chronic liver diseases.
- Analysis of MDSC mechanisms including T cell inhibition, cytokine dysregulation, and metabolic interference.
Main Results:
- MDSCs play dual roles in chronic liver diseases, exacerbating injury while modulating immune responses.
- MDSCs are pivotal regulators of disease progression in conditions like viral hepatitis, ALD, NAFLD, and AILD.
Conclusions:
- MDSCs are critical players in the pathogenesis of chronic liver diseases.
- Targeting MDSCs presents a promising therapeutic strategy for chronic liver disease management.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
01:29Chronic Pancreatitis II: Collaborative Care
133
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
133
01:17Chronic Bowel Disorders: Introduction
545
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
545